Skip to main content

Table 2 Morbidity and mortality of each group

From: Comparison if the addition of multilevel vertebral augmentation to conventional therapy will improve the outcome of patients with multiple myeloma

 

Group 1

Group 2

Morbidity

Threepatients bed ridden due to multiple spinal fracture and paraparesis.

Four patients can walk with aid

All still mobile without aid except one who needs stalk aid.

Mortality

Five patients: four deaths due to advancement of the disease and one due to sepsis after 7–11 months of treatment (38.5%)

Four patients:

one at the same day of surgery due to PE,

two after 1.5 year of treatment due to advancement of the disease and one after 1.5 years due to pneumonia. (27.3%)

Back Pain Improvement

Six patients improved partially

All patients improved after Vertebroplasty with three of them had episodes of pain.

Vertebroplasty Intraoperative Complications

----

One had small leak toward the spinal canal without neurological disorders.

One had intravascular leak.